Sort
64,565 grants matching “drug discovery”
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer
$2,287,595Robert J Coffey · Vanderbilt University Medical Center · P50 · FY2022 · CA
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
$2,286,821Paul M. Lieberman · Wistar Institute · P01 · FY2024 · CA
Pharmacokinetics and Drug Metabolism
$2,286,500Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Mayo Clinic Breast Cancer SPORE
$2,285,993Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2023 · CA
Pharmacogenomics of Arrhythmia Therapy
$2,285,709Dan M Roden · Vanderbilt University · U19 · FY2014 · HL
Disease mechanism and therapies for retinal degeneration
$2,283,094Tiansen Li · National Eye Institute · ZIA · FY2019 · EY
Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order
$2,282,554Richard Mayeux · Columbia University Health Sciences · R01 · FY2022 · AG
Basic Research Support for the CCR
$2,282,526James L. Gulley · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL
$2,281,452Jiawei Han · University Of Illinois At Urbana-Champaign · U54 · FY2015 · GM
Discovery of Chemical Probes and Therapeutic Leads
$2,281,256Joseph M Fox · University Of Delaware · P20 · FY2015 · GM
Genetic approaches to protein-protein interactions mediating antibiotic resistanc
$2,280,000Christopher J Kristich · Medical College Of Wisconsin · DP2 · FY2009 · OD
Controlling Stem Cell Fate through Computational Modeling
$2,280,000Jeremy Purvis · Univ Of North Carolina Chapel Hill · DP2 · FY2016 · HD
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer
$2,278,912Robert J Coffey · Vanderbilt University Medical Center · P50 · FY2023 · CA
Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Orders
$2,278,418Richard Mayeux · Columbia University Health Sciences · R56 · FY2019 · AG
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
$2,278,318Matthew D Ringel · Ohio State University · P50 · FY2017 · CA
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer
$2,278,098Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2019 · CA
SPORE in Prostate Cancer
$2,277,704Donald J. Tindall · Mayo Clinic Rochester · P50 · FY2007 · CA
Title: Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery, Evaluation and Development
$2,277,231Doug Smallwood · Fisher Bioservices, Inc. · N02 · FY2019 · CA
University of New Mexico Center for Metals in Biology and Medicine
$2,277,209Matthew J Campen · University Of New Mexico Health Scis Ctr · P20 · FY2021 · GM
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,277,012Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer
$2,276,968Robert J Coffey · Vanderbilt University Medical Center · P50 · FY2021 · CA
COG NCTN Year 12 BIQSFP Progress Report
$2,276,944Douglas S. Hawkins · Public Health Institute · U10 · FY2025 · CA
Institute for Biomedical and Health Disparities Research
$2,275,641Texas Southern University · G12 · FY2004 · RR
Training &Educ:Advance Multidise Clin Res (TEAM) (RMI)
$2,275,242University Of Wisconsin Madison · K12 · FY2005 · RR
Discovery of genetic interactions in cancer
$2,274,811Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA